Mechanistic Insights, Treatment Paradigms, and Clinical Progress in Neurological Disorders: Current and Future Prospects

被引:16
作者
Alkahtani, Saad [1 ]
AL-Johani, Norah S. S. [1 ]
Alarifi, Saud [1 ]
机构
[1] King Saud Univ, Coll Sci, Dept Zool, POB 2455, Riyadh 11451, Saudi Arabia
关键词
neurodegenerative diseases; central nervous system; Alzheimer's disease; Parkinson's disease; blood-brain barrier; oxidative stress; BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; DRUG-DELIVERY; NEUROVASCULAR DYSFUNCTION; INNATE IMMUNITY; GENE-THERAPY; ASTROCYTES; HEALTH; BETA;
D O I
10.3390/ijms24021340
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurodegenerative diseases (NDs) are a major cause of disability and are related to brain development. The neurological signs of brain lesions can vary from mild clinical shortfalls to more delicate and severe neurological/behavioral symptoms and learning disabilities, which are progressive. In this paper, we have tried to summarize a collective view of various NDs and their possible therapeutic outcomes. These diseases often occur as a consequence of the misfolding of proteins post-translation, as well as the dysfunctional trafficking of proteins. In the treatment of neurological disorders, a challenging hurdle to cross regarding drug delivery is the blood-brain barrier (BBB). The BBB plays a unique role in maintaining the homeostasis of the central nervous system (CNS) by exchanging components between the circulations and shielding the brain from neurotoxic pathogens and detrimental compounds. Here, we outline the current knowledge about BBB deterioration in the evolving brain, its origin, and therapeutic interventions. Additionally, we summarize the physiological scenarios of the BBB and its role in various cerebrovascular diseases. Overall, this information provides a detailed account of BBB functioning and the development of relevant treatments for neurological disorders. This paper will definitely help readers working in the field of neurological scientific communities.
引用
收藏
页数:18
相关论文
共 138 条
[1]   Developmental neurotoxicity of succeeding generations of insecticides [J].
Abreu-Villaca, Yael ;
Levin, Edward D. .
ENVIRONMENT INTERNATIONAL, 2017, 99 :55-77
[2]   Tissue Plasminogen Activator (tPA) and Matrix Metalloproteinases in the Pathogenesis of Stroke: Therapeutic Strategies [J].
Adibhatla, Rao Muralikrishna ;
Hatcher, James F. .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2008, 7 (03) :243-253
[3]   Overview of the Saudi National Mental Health Survey [J].
Al-Subaie, Abdullah S. ;
Al-Habeeb, AbdulHameed ;
Altwaijri, Yasmin A. .
INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH, 2020, 29 (03)
[4]   Mental health impact of COVID-19 on Saudi families and children with special educational needs and disabilities in Saudi Arabia: A national perspective [J].
Alenezi, Shuliweeh ;
Temsah, Mohamad-Hani ;
Alyahya, Ahmed S. ;
Almadani, Ahmad H. ;
Almarshedi, Afnan ;
Algazlan, Maha S. ;
Alnemary, Faisal ;
Bashiri, Fahad A. ;
Alkhawashki, Samah Hazem ;
Altuwariqi, Maram Hani ;
Alsedrani, Rafif ;
Alkhiri, Aqeel ;
Alarabi, Mohammed .
FRONTIERS IN PUBLIC HEALTH, 2022, 10
[5]   Mental illness in Saudi Arabia: an overview [J].
Almutairi, Adel F. .
PSYCHOLOGY RESEARCH AND BEHAVIOR MANAGEMENT, 2015, 8 :47-49
[6]   Natural Compounds for Alzheimer's Disease Therapy: A Systematic Review of Preclinical and Clinical Studies [J].
Andrade, Stephanie ;
Ramalho, Maria Joao ;
Loureiro, Joana Angelica ;
Pereira, Maria do Carmo .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (09)
[7]   Continuous dopaminergic stimulation by Duodopa® in advanced Parkinson's disease: Efficacy and safety [J].
Annic, A. ;
Devos, D. ;
Seguy, D. ;
Dujardin, K. ;
Destee, A. ;
Defebvre, L. .
REVUE NEUROLOGIQUE, 2009, 165 (8-9) :718-727
[8]  
[Anonymous], ALZH NEWS TOD
[9]  
[Anonymous], REPORT ALZHEIMERS DI
[10]  
[Anonymous], 2022, LAUNCH WHOS PARKINSO